Baxter lung drug promotion misleading -- US FDA - Reuters

[INCIID News Feed]

<img alt="" height="1" width="1" />
Baxter lung drug promotion misleading -- US FDA
Reuters
WASHINGTON, Aug 31 (Reuters) - US health officials have issued a warning to Baxter International Inc (BAX.N) for misleading patients and doctors about the benefits of its Aralast lung drug. In the warning released on Tuesday, the US Food and Drug ...
FDA issues warning to Baxter over drug promotionBusinessWeek
Baxter Gets FDA Warning On Brochure For Drug Aralast NPWall Street Journal
Natco reveals Revlimid patent challenge; Baxter warned on Aralast promotion;FiercePharma

all 18 news articles &raquo;


More...